Novo Nordisk A/S

NVO

$49.29

Name : Novo Nordisk A/S

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $219,178,680,320.00

EPSttm : 3.66

Novo Nordisk A/S

$49.29

0.74%

$0.36

Float Short %

0.94

Margin Of Safety %

Put/Call OI Ratio

0.83

EPS Next Q Diff

4.17

EPS Last/This Y

17.48

EPS This/Next Y

1.05

Price

48.93

Target Price

58.36

Analyst Recom

2.21

Performance Q

-0.45

Relative Volume

0.53

Beta

0.68

Ticker: NVO

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-14	NVO	58.9	0.79	0.43	1585092
2026-01-15	NVO	57.12	0.80	1.15	1606497
2026-01-16	NVO	62.32	0.84	0.42	1693378
2026-01-20	NVO	60.72	0.88	0.60	1328034
2026-01-21	NVO	59.32	0.84	0.64	1361008
2026-01-22	NVO	62.23	0.85	0.59	1422546
2026-01-23	NVO	62.27	0.87	0.35	1450815
2026-01-26	NVO	63.98	0.88	0.52	1371791
2026-01-27	NVO	62.82	0.87	0.58	1396499
2026-01-28	NVO	60.35	0.88	0.44	1409720
2026-01-29	NVO	59.33	0.88	1.23	1429014
2026-01-30	NVO	59.45	0.89	0.63	1450169
2026-02-02	NVO	58.94	0.84	0.80	1346822
2026-02-03	NVO	50.33	0.85	0.69	1372674
2026-02-04	NVO	47.23	0.88	0.63	1409799
2026-02-05	NVO	43.36	0.86	0.66	1469645
2026-02-06	NVO	47.68	0.80	0.73	1554469
2026-02-09	NVO	49.37	0.84	0.55	1474904
2026-02-10	NVO	49.1	0.84	0.39	1500076
2026-02-11	NVO	48.7	0.84	0.57	1520168
2026-02-12	NVO	48.94	0.83	0.94	1533245
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-14	NVO	58.92	-8.3	-2556.0	23.03
2026-01-15	NVO	57.12	-8.3	-2882.1	23.03
2026-01-16	NVO	62.35	-8.3	-497.6	23.03
2026-01-20	NVO	60.67	-7.9	-2278.8	23.03
2026-01-21	NVO	59.33	-7.9	-2725.3	23.03
2026-01-22	NVO	62.22	-7.9	-1016.4	23.03
2026-01-23	NVO	62.24	-7.9	-2170.9	23.03
2026-01-26	NVO	63.99	-6.4	-2069.7	23.03
2026-01-27	NVO	62.89	-6.4	-2266.5	23.03
2026-01-28	NVO	60.34	-6.9	-2891.8	23.03
2026-01-29	NVO	59.33	-6.9	-2606.4	23.03
2026-01-30	NVO	59.44	-6.9	-2020.1	23.03
2026-02-02	NVO	58.97	-6.9	-2126.3	23.03
2026-02-03	NVO	50.35	-6.9	-5065.2	23.03
2026-02-04	NVO	47.25	-6.9	-2943.5	23.03
2026-02-05	NVO	43.34	-22.7	-52.4	22.37
2026-02-06	NVO	47.68	-22.7	3960.9	22.37
2026-02-09	NVO	49.37	-23.9	1824.9	21.51
2026-02-10	NVO	49.10	-24.4	-2394.3	21.12
2026-02-11	NVO	48.73	-24.4	-2743.2	21.12
2026-02-12	NVO	48.93	-24.4	-2207.8	21.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-14	NVO	0	-1.33	0.96
2026-01-15	NVO	0	-1.33	0.96
2026-01-16	NVO	0	-1.33	0.96
2026-01-20	NVO	0	-1.66	0.96
2026-01-21	NVO	0	-1.66	0.96
2026-01-22	NVO	0	-1.66	0.96
2026-01-23	NVO	0	-1.66	0.96
2026-01-26	NVO	0	-1.52	0.96
2026-01-27	NVO	0	-1.52	0.96
2026-01-28	NVO	0	-1.52	0.84
2026-01-29	NVO	0	-1.52	0.84
2026-01-30	NVO	0	-1.52	0.84
2026-02-02	NVO	0	-1.57	0.84
2026-02-03	NVO	0	-1.57	0.84
2026-02-04	NVO	0	-1.57	0.84
2026-02-05	NVO	0	-1.57	0.84
2026-02-06	NVO	0	-1.57	0.84
2026-02-09	NVO	0	-1.17	0.84
2026-02-10	NVO	0	-1.17	0.84
2026-02-11	NVO	0	-1.17	0.94
2026-02-12	NVO	0	-1.17	0.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

4.94

Avg. EPS Est. Next Quarter

5.17

Insider Transactions

Institutional Transactions

-1.17

Beta

0.68

Average Sales Estimate Current Quarter

74945

Average Sales Estimate Next Quarter

70920

Fair Value

52.04

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-69.6

Target Price

58.36

P/E

14.11

Forward P/E

14.06

PEG

7.69

P/S

3.53

P/B

7.13

P/Free Cash Flow

18.42

EPS

3.47

Average EPS Est. Cur. Y

21.12

EPS Next Y. (Est.)

22.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

33.03

Relative Volume

0.53

Return on Equity vs Sector %

24.9

Return on Equity vs Industry %

16.7

EPS 1 7Days Diff

-1.2

EPS 1 30Days Diff

-0.56

EBIT Estimation

-2207.8

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 68794

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y